Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of allosteric mutant-selective EGFR inhibitor for the treatment of NSCLC

July 26, 2022

New SOS-1 inhibitors discovered at Chengdu Baiyu Pharmaceutical

July 26, 2022

Shanghai Institute of Materia Medica identifies new nagilactone derivatives

July 26, 2022

THR-beta agonists described by Shanghai Kunheng Pharmaceutical Technology, Kunming Pharmaceutical

July 26, 2022

Ultra-long-acting dolutegravir prodrug formulation may enhance treatment compliance

July 25, 2022

Androgen receptor-targeting PROTACs synthesized at Arvinas Operations

July 25, 2022

Thanks for the good memories: neurotensin codes for positive valence in associative learning

July 25, 2022

Ketamine-inspired compound shows efficacy in rat model of renal I/R injury

July 25, 2022

Sanofi to advance NK cell engager from Innate Pharma collaboration into IND-enabling studies

July 25, 2022

Vicebio launches to advance vaccines against respiratory viral infections

July 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...